Results for “ ”

Entry Author Date Location
Bio Roundup: Nationwide’s Rise, a Surgeon’s Quest, CRISPR USA & More 04/19/19 National
Redox Wrangles $33M to Become Healthcare’s Go-To Data Integrator 04/18/19 Wisconsin
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help 04/18/19 Boston
$100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants 04/18/19 Boston
PathAI Raises $60M in Quest to Be AI Assistant in the Exam Room 04/17/19 Boston
Flagship Pioneering Unveils Kintai’s Gut Approach to Treating Disease 04/16/19 Boston
Alzheimer’s, Gene Therapy & More: Agenda For “What’s Hot” on May 21 04/16/19 Boston
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon 04/15/19 New York
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy 04/15/19 National
Alnylam Makes Case For 2nd RNAi Drug at Big Liver Disease Meeting 04/12/19 Boston
Lyft, Uber, and the Changing Disclosure Rules For Unicorn IPOs 04/12/19 San Francisco
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout 04/12/19 New York
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More 04/12/19 National
Intercept Touts a Smaller Piece of Its NASH Trial at Liver Conference 04/11/19 New York
AskBio Reels In $235M to Advance Gene Therapy Clinical Trials 04/11/19 Raleigh Durham
Senators Grill Pharmacy Benefit Execs About Skyrocketing Drug Prices 04/09/19 National
VC Trends in 2019: More Money, Fewer Deals But Women Still Get Less 04/09/19 National
CD&R Buys Majority Stake in San Antonio’s Sirius Computer Solutions 04/08/19 Texas
Trevi Therapeutics Files for IPO to Fund Anti-Itching Drug R&D 04/08/19 New York
Four Things Every Smart Startup Should Do as It Scales 04/08/19 National
Alnylam Gets $800M From Regeneron to Bring RNAi to Eye, Brain Diseases 04/08/19 Boston
Celgene Files for FDA Approval of Blood Disease Drug 04/05/19 New York
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
As AVs Rev Up, the Data Privacy Fight Could Shift to Your Car 04/04/19 Detroit Ann Arbor
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
“FacePalm” Bug Is a Jarring Wake-Up Call. And Not Just for Apple 04/02/19 National
SpringWorks, Armed with Ex-Pfizer Cancer Drugs, Reloads with $125M 04/01/19 New York
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More 03/29/19 National
Lyft Raises $2.2B in IPO, Pegging Valuation at Over $24B 03/28/19 San Francisco
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch 03/28/19 San Diego
Page 1 of 284 next page »